Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo (NCT04941833) | Clinical Trial Compass
CompletedPhase 2/3
Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo
Thailand20 participantsStarted 2021-06-01
Plain-language summary
Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.
Who can participate
Age range
15 Years – 49 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Thai female and foreigner who can understand Thai language
* Age 15-49 years
* Diagnose as endometrioma sized more than 3 cm
* Underwent to surgery in next 13 weeks
Exclusion Criteria:
* History of endometriosis
* Pregnancy woman
* Contraindication for desogestrel : History of thrombotic event, Autoimmune disease,gestational trophoblastic disease
* Ovarian endometrioma with complications : Ruptured, twisted
* Contraindications for NSAIDs : Peptic ulcer, thrombocytopenia, liver disease
* History of hormonal treatment for endometrioma : DMPA,OCP, GNRH agonist/antoginist
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Cyst diameter
Timeframe: 3 months after drug given
Trial details
NCT IDNCT04941833
SponsorDepartment of Medical Services Ministry of Public Health of Thailand